SCHEMBL1963995

SCHEMBL1963995

NC(=O)N1CCCCC1c1cccnn1

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PRMT5 O14744 1/20 0.39
WDR77 Q9BQA1 1/20 0.39
BTK Q06187 2/20 0.38
KDM5A P29375 1/20 0.37
KDM4E B2RXH2 2/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
GRM5 P41594 1/20 0.35
LMNA P02545 1/20 0.35
USP2 O75604 1/20 0.35
PABPC1 P11940 1/20 0.35
CPT1A P50416 3/20 0.35
CPT1B Q92523 1/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
DAGLA Q9Y4D2 1/20 0.35
NFE2L2 Q16236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17620811 0.90 KDM5A (0.37) BTKKDM5AKDM4EMEN1KMT2A
SCHEMBL31430923 0.82 PRMT5 (0.55) PRMT5WDR77BTKGRM5CPT1A
SCHEMBL29504572 0.82 PRMT5 (0.55) PRMT5WDR77BTKGRM5CPT1A
SCHEMBL31590042 0.81 ALDH1A1 (0.44) PRMT5WDR77KDM4EMEN1KMT2A
SCHEMBL38659451 0.77 HSD11B1 (0.51) PRMT5WDR77GRM5CPT1AALDH1A1
SCHEMBL8296762 0.77 HSD11B1 (0.51) PRMT5WDR77GRM5CPT1AALDH1A1
SCHEMBL1962198 0.75 CHRNB2 (0.59) PRMT5WDR77KDM4EMEN1KMT2A
SCHEMBL28292819 0.75 CPT1A (0.42) PRMT5WDR77KDM5AGRM5CPT1A
SCHEMBL31430919 0.75 CHRNB2 (0.59) PRMT5WDR77KDM4EMEN1KMT2A
SCHEMBL1297872 0.74 PARP1 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144159-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS PFIZER INC 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144159-A1 ETHER BENZYLIDENE PIPERIDINE ARYL CARBOXAMIDE COMPOUNDS USEFUL AS FAAH INHIBITORS FAAH, FAAH2, PAH PRMT5 2843/4885WDR77 1887/4885BTK 3037/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.